drugset / Trial / NCT00834977

Amlodipine-Benazepril 10mg-20mg Capsules in Healthy Subjects Under Fasting Conditions

NCT00834977

Phase 1 Completed 48 enrolled Teva Pharmaceuticals USA
RandomizedCrossoverOpen-labelOther

Summary

The objective of this study is to compare the rate and extent of absorption of amlodipine-benzazepril 10 mg-20 mg capsules (test) versus Lotrel® (reference), administered as 1 x 10 mg capsule under fasting conditions.

Timeline

Start
2004-04
Primary completion
2004-05
Completion
2004-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Amlodipine Other / unclassified 10 mg
Subject Benazepril Unknown 20 mg

Indications

No indication recorded.